Kovitz Investment Group Partners’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,004	Closed	-$172K	–	1315
2024 Q4	$172K	Sell	13,004 -12,452	-49%	-$171K	﹤0.01%	1181
2024 Q3	$314K	Buy	25,456 +1,670	+7%	+$23.7K	﹤0.01%	861
2024 Q2	$308K	Buy	23,786 +490	+2%	+$6.49K	﹤0.01%	726
2024 Q1	$324K	Buy	+23,296	New	+$339K	﹤0.01%	573
2022 Q1	–	Sell	-77,956	Closed	-$1.42M	–	460
2021 Q4	$1.42M	Sell	77,956 -158,814	-67%	-$2.23M	0.03%	238
2021 Q3	$3.88M	Buy	236,770 +1,432	+0.6%	+$24K	0.08%	174
2021 Q2	$3.96M	Buy	235,338 +157,558	+203%	+$2.68M	0.08%	177
2021 Q1	$1.42M	Sell	77,780 -175	-0.2%	-$3.15K	0.03%	244
2020 Q4	$1.42M	Sell	77,955 -9,784	-11%	-$172K	0.03%	232
2020 Q3	$1.56M	Sell	87,739 -6,627	-7%	-$121K	0.04%	213
2020 Q2	$1.69M	Sell	94,366 -8,082	-8%	-$145K	0.05%	196
2020 Q1	$1.55M	Sell	102,448 -11,682	-10%	-$212K	0.06%	198
2019 Q4	$2.25M	Sell	114,130 -53,741	-32%	-$1.03M	0.07%	189
2019 Q3	$2.89M	Sell	167,871 -39,242	-19%	-$679K	0.09%	157
2019 Q2	$3.67M	Sell	207,113 -36,476	-15%	-$664K	0.12%	135
2019 Q1	$4.96M	Buy	+243,589	New	+$4.9M	0.16%	98